Neville Rodie & Shaw Inc Abbott Laboratories Transaction History

Neville Rodie & Shaw Inc

  • $1.37 Billion
  • Q4 2024

A detailed history of Neville Rodie & Shaw Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 48,570 shares of ABT stock, worth $6.34 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
48,570
Previous 48,870 0.61%
Holding current value
$6.34 Million
Previous $5.57 Million 1.4%
% of portfolio
0.4%
Previous 0.41%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025
SELL
$111.93 - $119.39 $33,579 - $35,817
-300 Reduced 0.61%
48,570 $5.49 Million
Q3 2024

Oct 01, 2024
SELL
$100.07 - $118.13 $68,547 - $80,919
-685 Reduced 1.38%
48,870 $5.57 Million
Q2 2024

Jul 01, 2024
SELL
$100.73 - $112.44 $75,547 - $84,330
-750 Reduced 1.49%
49,555 $5.15 Million
Q1 2024

Apr 09, 2024
SELL
$109.52 - $120.96 $280,918 - $310,262
-2,565 Reduced 4.85%
50,305 $5.72 Million
Q4 2023

Jan 02, 2024
SELL
$90.19 - $110.4 $121,756 - $149,040
-1,350 Reduced 2.49%
52,870 $5.82 Million
Q3 2023

Oct 10, 2023
SELL
$95.53 - $114.62 $15,284 - $18,339
-160 Reduced 0.29%
54,220 $5.25 Million
Q2 2023

Jul 06, 2023
BUY
$100.78 - $112.29 $7,558 - $8,421
75 Added 0.14%
54,380 $5.93 Million
Q1 2023

Apr 04, 2023
BUY
$96.86 - $114.01 $87,174 - $102,609
900 Added 1.69%
54,305 $5.5 Million
Q3 2022

Oct 04, 2022
SELL
$96.76 - $112.03 $40,155 - $46,492
-415 Reduced 0.77%
53,405 $5.17 Million
Q2 2022

Jul 06, 2022
SELL
$102.07 - $123.37 $63,793 - $77,106
-625 Reduced 1.15%
53,820 $5.85 Million
Q1 2022

Apr 05, 2022
SELL
$114.02 - $139.04 $45,151 - $55,059
-396 Reduced 0.72%
54,445 $6.46 Million
Q4 2021

Jan 05, 2022
SELL
$115.53 - $141.46 $63,541 - $77,803
-550 Reduced 0.99%
54,841 $7.72 Million
Q3 2021

Oct 06, 2021
SELL
$116.66 - $129.06 $46,664 - $51,624
-400 Reduced 0.72%
55,391 $6.54 Million
Q2 2021

Jul 06, 2021
SELL
$105.79 - $124.53 $25,601 - $30,136
-242 Reduced 0.43%
55,791 $6.47 Million
Q1 2021

Apr 08, 2021
SELL
$108.84 - $128.23 $326,520 - $384,689
-3,000 Reduced 5.08%
56,033 $6.72 Million
Q3 2020

Oct 01, 2020
BUY
$91.64 - $111.29 $158,262 - $192,197
1,727 Added 3.01%
59,033 $6.42 Million
Q2 2020

Jul 15, 2020
SELL
$76.57 - $98.0 $34,150 - $43,708
-446 Reduced 0.77%
57,306 $5.24 Million
Q1 2020

Apr 01, 2020
SELL
$62.82 - $91.86 $45,921 - $67,149
-731 Reduced 1.25%
57,752 $4.56 Million
Q4 2019

Jan 08, 2020
SELL
$78.51 - $87.4 $39,255 - $43,700
-500 Reduced 0.85%
58,483 $5.08 Million
Q3 2019

Oct 02, 2019
SELL
$81.84 - $88.74 $111,302 - $120,686
-1,360 Reduced 2.25%
58,983 $4.94 Million
Q2 2019

Jul 01, 2019
SELL
$72.88 - $85.0 $218,421 - $254,745
-2,997 Reduced 4.73%
60,343 $5.08 Million
Q1 2019

Apr 08, 2019
SELL
$66.22 - $80.06 $161,311 - $195,026
-2,436 Reduced 3.7%
63,340 $5.06 Million
Q4 2018

Jan 03, 2019
SELL
$65.56 - $74.27 $68,838 - $77,983
-1,050 Reduced 1.57%
65,776 $4.76 Million
Q3 2018

Oct 09, 2018
BUY
$60.81 - $73.36 $60,749 - $73,286
999 Added 1.52%
66,826 $4.9 Million
Q2 2018

Jul 03, 2018
SELL
$57.57 - $63.54 $28,785 - $31,770
-500 Reduced 0.75%
65,827 $4.02 Million
Q1 2018

Apr 12, 2018
SELL
$56.27 - $63.62 $14,067 - $15,905
-250 Reduced 0.38%
66,327 $3.98 Million
Q4 2017

Jan 03, 2018
BUY
$53.68 - $57.47 $8,213 - $8,792
153 Added 0.23%
66,577 $3.8 Million
Q3 2017

Oct 03, 2017
BUY
$48.06 - $53.64 $3.19 Million - $3.56 Million
66,424
66,424 $3.55 Million

Others Institutions Holding ABT

# of Institutions
3,290
Shares Held
1.34B
Call Options Held
9.72M
Put Options Held
8.45M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email